Clinical trial
Significance of Biological Markers in Patients With Acute Lung Injury/Acute…
NCT00217880 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00217880 |
|---|---|
| Title | Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease |
| Official title | Prognostic Significance of Biological Markers in Patients With ALI/ARDS |
| Lead sponsor | University of Michigan, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult |
| Intervention type | Procedure |
| Interventions | Bronchoscopy |
| Enrollment | 40 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: